Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02636101 | Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study | ||
| NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | ||
| NCT04794569 | Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome | ||
| NCT00704262 | Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds | ||
| NCT01930396 | Use of Tinzaparin for Anticoagulation in Hemodialysis | ||
| NCT03806790 | Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris | ||
| NCT00031096 | Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne | ||
| NCT03569345 | Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate | ||
| NCT01580488 | A Plaque Test Study With LEO 35299 in Psoriasis Vulgaris | ||
| NCT02518048 | A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris | ||
| NCT01982552 | An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life | ||
| NCT03115476 | A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp | ||
| NCT02549352 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up | ||
| NCT04203836 | A Trial to Evaluate the Effect of Food on LEO 152020 | ||
| NCT00203658 | Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin | ||
| NCT03788863 | A Study to Learn More About the Relationship Between the Development of a Gap in the Upper Lip (Cleft Lip) or in the Roof of the Mouth (Cleft Palate) in Newborns and the Use of Glucocorticoids by the Mother During Pregnancy: a Meta-analysis | ||
| NCT07487948 | Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris | ||
| NCT02602470 | Preferences & Treatment Satisfaction Drivers in Rosacea Patients | ||
| NCT00403949 | A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis | ||
| NCT05050279 | A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People | ||
| NCT02547233 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up | ||
| NCT06386107 | Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis | ||
| NCT01449513 | PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy | ||
| NCT00185510 | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis | ||
| NCT03231124 | Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects. | ||
| NCT02496546 | An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD) | ||
| NCT02100813 | Safety and Efficacy of Doses of LEO 43204 Once Daily for Two Consecutive Days on Full Balding Scalp in Subjects With Actinic Keratosis | ||
| NCT02090465 | Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks | ||
| NCT01257919 | Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea | ||
| NCT02549339 | Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up | ||
| NCT01892137 | Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05% | ||
| NCT01167309 | LEO 27847 - Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Secondary Hyperparathyroidism Patients | ||
| NCT01083758 | Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis | ||
| NCT02668692 | LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis | ||
| NCT03673527 | Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin | ||
| NCT00855595 | Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea | ||
| NCT00833872 | LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects | ||
| NCT00506519 | Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe Sepsis | ||
| NCT04361136 | Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream | ||
| NCT01211964 | LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects | ||
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | ||
| NCT03725722 | Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis. | ||
| NCT02406014 | Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp | ||
| NCT01926496 | Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% | ||
| NCT02354391 | Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis | ||
| NCT01423656 | Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 | ||
| NCT00243464 | Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis | ||
| NCT02594436 | The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice | ||
| NCT01188928 | LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) | ||
| NCT05117060 | Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis |
